Skip to Content

Register Today!

Not a member? Join the ACLA to take advantage of all member benefits.

Register Now Join Today

Annual Meeting 2022

The American Comparative Literature Association's 2022 Annual Meeting will take place June 15-18, 2022.

Join us for the 2022 Annual Meeting at National Taiwan Normal University, June 15-18, 2022. This will be a fully in person conference. 

Conference Timeline

08.15.2021 - 09.30.2021 Call for seminar proposals
10.01.2021 - 10.31.2021 Call for papers
11.01.2021 - 11.09.2021 Seminar organizers review paper submissions
11.10.2021 - 11.24.2021 ACLA Program committee reviews all seminar submissions
11.25.2021 - 12.15.2021 Final decisions sent to all applicants
January 2022 Travel Grant winners will be announced
June 15-18, 2022 ACLA 2022 Annual Meeting


The ACLA will reserve a small room block close to the university and encourages all attendees to plan to seek out their own accommodations. Return to this page in September 2021 for a list of local hotels close to the conference site. All attendees will also be welcome to communicate on our Room Share forum that will also go live in September.

Travel Grants

The ACLA is proud to offer an increased fund for the 2022 travel grants for contingent faculty and graduate students. Return to the site in Fall 2021 for application information.


Watch the video below to learn more about our university host, NTNU.

2022 Registration Rates
$195.00 | Faculty
$95.00 | Independent Scholar
$76.00 | Contingent Faculty (Reduced 20% from $95.00)
$95.00 | Retired Faculty
$68.00 | Graduate student (Reduced 20% from $85.00)
$35.00 | Undergraduate
**Conference registration will open in August 2021 during the call for seminar submissions.

Contingency Plan
In view of the ongoing pandemic, the 2022 conference may need to be moved online again. The board has developed a contingency plan and will make a final decision in January 2022.  ACLA welcomes your feedback and will be happy to take your questions and listen to concerns about the 2022 conference.  We appreciate your continuing patience and support.